Brian Soreghan

2.9k total citations · 2 hit papers
13 papers, 2.4k citations indexed

About

Brian Soreghan is a scholar working on Molecular Biology, Physiology and Biomaterials. According to data from OpenAlex, Brian Soreghan has authored 13 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 6 papers in Physiology and 4 papers in Biomaterials. Recurrent topics in Brian Soreghan's work include Alzheimer's disease research and treatments (6 papers), Supramolecular Self-Assembly in Materials (3 papers) and Computational Drug Discovery Methods (3 papers). Brian Soreghan is often cited by papers focused on Alzheimer's disease research and treatments (6 papers), Supramolecular Self-Assembly in Materials (3 papers) and Computational Drug Discovery Methods (3 papers). Brian Soreghan collaborates with scholars based in United States, Italy and Germany. Brian Soreghan's co-authors include Joseph V. Kosmoski, Andrzej S. Tarnawski, Mary F. Knauer, Rama Pai, Imre Szabó, Charles Glabe, Dolgor Baatar, C.G. Glabe, Min‐Sung Kwon and John R. Yates and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Medicine.

In The Last Decade

Brian Soreghan

13 papers receiving 2.4k citations

Hit Papers

Assembly and aggregation properties of synthetic Alzheime... 1992 2026 2003 2014 1992 2002 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Assembly and aggregation properties of synthetic Alzheimer's A4/beta amyloid peptide analogs.
    1992 860 citations Debra Burdick, Brian Soreghan et al. Journal of Biological Chemistry profile →
  2. Prostaglandin E2 transactivates EGF receptor: A novel mechanism for promoting colon cancer growth and gastrointestinal hypertrophy
    2002 690 citations Rama Pai, Brian Soreghan et al. Nature Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Brian Soreghan United States 13 1.2k 1.2k 644 358 256 13 2.4k
Shili Wu United States 18 1.2k 1.0× 2.2k 1.9× 488 0.8× 271 0.8× 518 2.0× 34 3.5k
William P. Esler United States 23 2.2k 1.8× 1.8k 1.5× 477 0.7× 242 0.7× 445 1.7× 40 3.4k
Tracy O’Connor Switzerland 14 1.2k 1.0× 1.4k 1.2× 301 0.5× 484 1.4× 164 0.6× 23 3.2k
Xiaoxiang Zhu United States 28 382 0.3× 1.8k 1.5× 693 1.1× 421 1.2× 444 1.7× 48 3.1k
Austin J. Yang United States 29 1.5k 1.3× 1.8k 1.6× 347 0.5× 208 0.6× 123 0.5× 59 3.2k
Adam A. Golabek United States 25 2.0k 1.6× 1.4k 1.2× 318 0.5× 245 0.7× 272 1.1× 51 2.8k
Shinobu Kitazume Japan 35 916 0.7× 2.4k 2.1× 247 0.4× 206 0.6× 174 0.7× 92 3.4k
Deryk Loo United States 21 827 0.7× 1.5k 1.3× 258 0.4× 663 1.9× 74 0.3× 44 3.4k
Akio Fukumori Germany 27 1.1k 0.9× 974 0.8× 357 0.6× 265 0.7× 324 1.3× 49 1.9k
Frances Prelli United States 42 2.8k 2.3× 4.2k 3.6× 331 0.5× 305 0.9× 320 1.3× 89 5.6k

Countries citing papers authored by Brian Soreghan

Since Specialization
Citations

This map shows the geographic impact of Brian Soreghan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian Soreghan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian Soreghan more than expected).

Fields of papers citing papers by Brian Soreghan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brian Soreghan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian Soreghan. The network helps show where Brian Soreghan may publish in the future.

Co-authorship network of co-authors of Brian Soreghan

This figure shows the co-authorship network connecting the top 25 collaborators of Brian Soreghan. A scholar is included among the top collaborators of Brian Soreghan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brian Soreghan. Brian Soreghan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Miyagishima, Kiyoharu J., et al.. (2013). Functional Comparison of Rod and Cone Gαt on the Regulation of Light Sensitivity*. Journal of Biological Chemistry. 288(8). 5257–5267. 19 indexed citations
2.
Soreghan, Brian, Stefani N. Thomas, & Austin J. Yang. (2003). Aberrant sphingomyelin/ceramide metabolic-induced neuronal endosomal/lysosomal dysfunction: potential pathological consequences in age-related neurodegeneration. Advanced Drug Delivery Reviews. 55(11). 1515–1524. 53 indexed citations
3.
Saito, Mariko, Tina L. Tekirian, Martin J. Berg, et al.. (2003). Neuronal endosomal/lysosomal membrane destabilization activates caspases and induces abnormal accumulation of the lipid secondary messenger ceramide. Brain Research Bulletin. 59(6). 523–531. 31 indexed citations
4.
Glabe, Charles, et al.. (2002). The Influence of the Carboxyl Terminus of the Alzheimer Aβ Peptide on its Conformation, Aggregation, and Neurotoxic Properties. NeuroMolecular Medicine. 1(1). 81–94. 16 indexed citations
5.
Pai, Rama, et al.. (2002). Prostaglandin E2 transactivates EGF receptor: A novel mechanism for promoting colon cancer growth and gastrointestinal hypertrophy. Nature Medicine. 8(3). 289–293. 690 indexed citations breakdown →
6.
Szabó, Imre, Rama Pai, Brian Soreghan, et al.. (2001). NSAIDs inhibit the activation of egr-1 gene in microvascular endothelial cells. A key to inhibition of angiogenesis?. Journal of Physiology-Paris. 95(1-6). 379–383. 25 indexed citations
7.
Husain, Syeda S., Imre Szabó, Rama Pai, et al.. (2001). MAPK (ERK2) kinase—a key target for NSAIDs-induced inhibition of gastric cancer cell proliferation and growth. Life Sciences. 69(25-26). 3045–3054. 53 indexed citations
8.
Tarnawski, Andrzej S., Imre Szabó, Syeda S. Husain, & Brian Soreghan. (2001). Regeneration of gastric mucosa during ulcer healing is triggered by growth factors and signal transduction pathways. Journal of Physiology-Paris. 95(1-6). 337–344. 125 indexed citations
9.
Cribbs, David H., Peter Velázquez, Brian Soreghan, Charles Glabe, & Andrea J. Tenner. (1997). Complement activation by cross-linked truncated and chimeric full-length β-amyloid. Neuroreport. 8(16). 3457–3462. 25 indexed citations
10.
Soreghan, Brian, Joseph V. Kosmoski, & Charles Glabe. (1994). Surfactant properties of Alzheimer's A beta peptides and the mechanism of amyloid aggregation.. Journal of Biological Chemistry. 269(46). 28551–28554. 236 indexed citations
11.
Burdick, Debra, Brian Soreghan, Min‐Sung Kwon, et al.. (1992). Assembly and aggregation properties of synthetic Alzheimer's A4/beta amyloid peptide analogs.. Journal of Biological Chemistry. 267(1). 546–554. 860 indexed citations breakdown →
12.
Knauer, Mary F., Brian Soreghan, Daniel Burdick, Joseph V. Kosmoski, & Charles Glabe. (1992). Intracellular accumulation and resistance to degradation of the Alzheimer amyloid A4/beta protein.. Proceedings of the National Academy of Sciences. 89(16). 7437–7441. 198 indexed citations
13.
Svensson, E. C., Brian Soreghan, & James C. Paulson. (1990). Organization of the beta-galactoside alpha 2,6-sialyltransferase gene. Evidence for the transcriptional regulation of terminal glycosylation.. Journal of Biological Chemistry. 265(34). 20863–20868. 100 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shili Wu Breakdown of academic impact, for papers by William P. Esler Breakdown of academic impact, for papers by Tracy O’Connor Breakdown of academic impact, for papers by Xiaoxiang Zhu Breakdown of academic impact, for papers by Austin J. Yang Breakdown of academic impact, for papers by Adam A. Golabek Breakdown of academic impact, for papers by Shinobu Kitazume Breakdown of academic impact, for papers by Deryk Loo Breakdown of academic impact, for papers by Akio Fukumori Breakdown of academic impact, for papers by Frances Prelli
Rankless by CCL
2026